Deltex Medical Group plc
DTXMF
$0.0952
$0.09223,073.33%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.24M | 2.24M | 2.21M | 2.54M | 2.86M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.24M | 2.24M | 2.21M | 2.54M | 2.86M |
| Cost of Revenue | 847.80K | 832.30K | 809.50K | 808.70K | 804.50K |
| Gross Profit | 1.40M | 1.40M | 1.40M | 1.73M | 2.06M |
| SG&A Expenses | 1.96M | 2.09M | 2.19M | 2.52M | 2.84M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -165.60K | -190.60K | -214.90K | -157.00K | -97.50K |
| Total Operating Expenses | 3.14M | 3.12M | 3.06M | 3.44M | 3.82M |
| Operating Income | -896.40K | -878.60K | -851.60K | -905.30K | -956.30K |
| Income Before Tax | -1.63M | -1.62M | -1.60M | -1.42M | -1.23M |
| Income Tax Expenses | -1.20K | -600.00 | 0.00 | 0.00 | 0.00 |
| Earnings from Continuing Operations | -1.62 | -1.62 | -1.60 | -1.42 | -1.23 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.62M | -1.62M | -1.60M | -1.42M | -1.23M |
| EBIT | -896.40K | -878.60K | -851.60K | -905.30K | -956.30K |
| EBITDA | -818.20K | -801.20K | -775.80K | -842.00K | -905.90K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 7.10B | 5.91B | 4.72B | 3.76B | 2.80B |
| Average Diluted Shares Outstanding | 7.10B | 5.91B | 4.72B | 3.76B | 2.80B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
